Skip to main content
Lancet (London, England)
After asthma: redefining airways diseases.
Idiopathic pulmonary fibrosis.
HIV moments and pre-exposure prophylaxis.
Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management.
Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II).
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial.
